MicroRNA-155 Suppresses Activation-Induced Cytidine Deaminase-Mediated Myc-Igh Translocation

Immunity

Volumn 28, Issue 5, 2008, Pages 630-638

  Dorsett, Yair ^a   McBride, Kevin M ^a   Jankovic, Mila ^a   Gazumyan, Anna ^a,b   Thai, To Ha ^c   Robbiani, Davide F ^a   Di Virgilio, Michela ^a   San Martin, Bernardo Reina ^d   Heidkamp, Gordon ^a   Schwickert, Tanja A ^a   Eisenreich, Thomas ^a   Rajewsky, Klaus ^c   Nussenzweig, Michel C ^a,b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

MOLIMMUNO

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; MESSENGER RNA; MICRORNA; MICRORNA 155;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; BINDING SITE; CHROMOSOME TRANSLOCATION; ENZYME REPRESSION; GENE MUTATION; GENE TRANSLOCATION; GENETIC VARIABILITY; HALF LIFE TIME; IMMUNOGLOBULIN GENE; IN VIVO STUDY; MOUSE; NONHUMAN; ONCOGENE MYC; PHENOTYPE; PHYSIOLOGY; PRIORITY JOURNAL; STEADY STATE;

3' UNTRANSLATED REGIONS; ANIMALS; B-LYMPHOCYTES; CYTIDINE DEAMINASE; GENES, IMMUNOGLOBULIN; GENES, MYC; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN HEAVY CHAINS; LIPOPOLYSACCHARIDES; MICE; MICE, MUTANT STRAINS; MICRORNAS; MUTATION; RNA STABILITY; RNA, MESSENGER; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; TRANSLOCATION, GENETIC;

EID: 43049173617     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2008.04.002     Document Type: Article

References (72)

1. Adams J.M., Harris A.W., Pinkert C.A., Corcoran L.M., Alexander W.S., Cory S., Palmiter R.D., and Brinster R.L. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318 (1985) 533-538
2. Barreto V.M., Pan-Hammarstrom Q., Zhao Y., Hammarstrom L., Misulovin Z., and Nussenzweig M.C. AID from bony fish catalyzes class switch recombination. J. Exp. Med. 202 (2005) 733-738
3. Bartel D.P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116 (2004) 281-297
4. Basu U., Chaudhuri J., Alpert C., Dutt S., Ranganath S., Li G., Schrum J.P., Manis J.P., and Alt F.W. The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation. Nature 438 (2005) 508-511
5. Chatterji M., Unniraman S., McBride K.M., and Schatz D.G. Role of activation-induced deaminase protein kinase A phosphorylation sites in Ig gene conversion and somatic hypermutation. J. Immunol. 179 (2007) 5274-5280
6. Choi W.Y., Giraldez A.J., and Schier A.F. Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. Science 318 (2007) 271-274
7. Conticello S.G., Thomas C.J., Petersen-Mahrt S.K., and Neuberger M.S. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol. Biol. Evol. 22 (2005) 367-377
8. Conticello S.G., Langlois M.A., Yang Z., and Neuberger M.S. DNA deamination in immunity: AID in the context of its APOBEC relatives. Adv. Immunol. 94 (2007) 37-73
9. Costinean S., Zanesi N., Pekarsky Y., Tili E., Volinia S., Heerema N., and Croce C.M. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc. Natl. Acad. Sci. USA 103 (2006) 7024-7029
10. Di Noia J.M., and Neuberger M.S. Molecular mechanisms of antibody somatic hypermutation. Annu. Rev. Biochem. 76 (2007) 1-22
11. Dorsett Y., Robbiani D.F., Jankovic M., Reina-San-Martin B., Eisenreich T.R., and Nussenzweig M.C. A role for AID in chromosome translocations between c-myc and the IgH variable region. J. Exp. Med. 204 (2007) 2225-2232
12. Eis P.S., Tam W., Sun L., Chadburn A., Li Z., Gomez M.F., Lund E., and Dahlberg J.E. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. USA 102 (2005) 3627-3632
13. Esquela-Kerscher A., and Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6 (2006) 259-269
14. Filipowicz W., Bhattacharyya S.N., and Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat. Rev. Genet. 9 (2008) 102-114
15. Fulci V., Chiaretti S., Goldoni M., Azzalin G., Carucci N., Tavolaro S., Castellano L., Magrelli A., Citarella F., Messina M., et al. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 109 (2007) 4944-4951
16. Gironella M., Seux M., Xie M.-J., Cano C., Tomasini R., Gommeaux J., Garcia S., Nowak J., Yeung M.L., Jeang K.-T., et al. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc. Natl. Acad. Sci. USA 104 (2007) 16170-16175
17. Gonda H., Sugai M., Nambu Y., Katakai T., Agata Y., Mori K.J., Yokota Y., and Shimizu A. The balance between Pax5 and Id2 activities is the key to AID gene expression. J. Exp. Med. 198 (2003) 1427-1437
18. Haasch D., Chen Y.W., Reilly R.M., Chiou X.G., Koterski S., Smith M.L., Kroeger P., McWeeny K., Halbert D.N., Mollison K.W., et al. T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. Cell. Immunol. 217 (2002) 78-86
19. Hammond S.M. MicroRNAs as tumor suppressors. Nat. Genet. 39 (2007) 582-583
20. Horikawa K., and Takatsu K. Interleukin-5 regulates genes involved in B-cell terminal maturation. Immunology 118 (2006) 497-508
21. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., Magri E., Pedriali M., Fabbri M., Campiglio M., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65 (2005) 7065-7070
22. Jay C., Nemunaitis J., Chen P., Fulgham P., and Tong A.W. miRNA profiling for diagnosis and prognosis of human cancer. DNA Cell Biol. 26 (2007) 293-300
23. John B., Enright A.J., Aravin A., Tuschl T., Sander C., and Marks D.S. Human MicroRNA targets. PLoS Biol. 2 (2004) e363
24. Jolly C.J., Klix N., and Neuberger M.S. Rapid methods for the analysis of immunoglobulin gene hypermutation: application to transgenic and gene targeted mice. Nucleic Acids Res. 25 (1997) 1913-1919
25. Klein U., and Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat. Rev. Immunol. 8 (2008) 22-33
26. Kluiver J., Poppema S., de Jong D., Blokzijl T., Harms G., Jacobs S., Kroesen B.J., and van den Berg A. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J. Pathol. 207 (2005) 243-249
27. Kluiver J., Haralambieva E., de Jong D., Blokzijl T., Jacobs S., Kroesen B.J., Poppema S., and van den Berg A. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer 45 (2006) 147-153
28. Kluiver J., van den Berg A., de Jong D., Blokzijl T., Harms G., Bouwman E., Jacobs S., Poppema S., and Kroesen B.J. Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma. Oncogene 26 (2007) 3769-3776
29. Kuppers R., and Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20 (2001) 5580-5594
30. Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W., and Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12 (2002) 735-739
31. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., Pfeffer S., Rice A., Kamphorst A.O., Landthaler M., et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129 (2007) 1401-1414
32. Lawrie C.H., Soneji S., Marafioti T., Cooper C.D., Palazzo S., Paterson J.C., Cattan H., Enver T., Mager R., Boultwood J., et al. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int. J. Cancer 121 (2007) 1156-1161
33. Lee E.J., Gusev Y., Jiang J., Nuovo G.J., Lerner M.R., Frankel W.L., Morgan D.L., Postier R.G., Brackett D.J., and Schmittgen T.D. Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer 120 (2007) 1046-1054
34. Leung A.K., and Sharp P.A. microRNAs: a safeguard against turmoil?. Cell 130 (2007) 581-585
35. Lewis B.P., Burge C.B., and Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (2005) 15-20
36. Lewis B.P., Shih I.h., Jones-Rhoades M.W., Bartel D.P., and Burge C.B. Prediction of mammalian microRNA targets. Cell 115 (2003) 787-798
37. Liu M., Duke J.L., Richter D.J., Vinuesa C.G., Goodnow C.C., Kleinstein S.H., and Schatz D.G. Two levels of protection for the B cell genome during somatic hypermutation. Nature 451 (2008) 841-845
38. Marton S., Garcia M.R., Robello C., Persson H., Trajtenberg F., Pritsch O., Rovira C., Naya H., Dighiero G., and Cayota A. Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. Leukemia 22 (2008) 330-338
39. Mayr C., Hemann M.T., and Bartel D.P. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315 (2007) 1576-1579
40. McBride K.M., Barreto V., Ramiro A.R., Stavropoulos P., and Nussenzweig M.C. Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase. J. Exp. Med. 199 (2004) 1235-1244
41. McBride K.M., Gazumyan A., Woo E.M., Barreto V.M., Robbiani D.F., Chait B.T., and Nussenzweig M.C. Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation. Proc. Natl. Acad. Sci. USA 103 (2006) 8798-8803
42. Meffre E., Casellas R., and Nussenzweig M.C. Antibody regulation of B cell development. Nat. Immunol. 1 (2000) 379-385
43. Meister G., and Tuschl T. Mechanisms of gene silencing by double-stranded RNA. Nature 431 (2004) 343-349
44. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., and Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102 (2000) 553-563
45. Muramatsu M., Nagaoka H., Shinkura R., Begum N.A., and Honjo T. Discovery of activation-induced cytidine deaminase, the engraver of antibody memory. Adv. Immunol. 94 (2007) 1-36
46. Muto T., Okazaki I.M., Yamada S., Tanaka Y., Kinoshita K., Muramatsu M., Nagaoka H., and Honjo T. Negative regulation of activation-induced cytidine deaminase in B cells. Proc. Natl. Acad. Sci. USA 103 (2006) 2752-2757
47. Nikiforova M.N., Tseng G.C., Steward D., Diorio D., and Nikiforov Y.E. MicroRNA expression profiling of thyroid tumors: Biological significance and diagnostic utility. J. Clin. Endocrinol. Metab. (2008) 10.1210/jc.2007-2696 in press. Published online February 12, 2008
48. Pasqualucci L., Kitaura Y., Gu H., and Dalla-Favera R. PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. Proc. Natl. Acad. Sci. USA 103 (2006) 395-400
49. Perez-Duran P., de Yebenes V.G., and Ramiro A.R. Oncogenic events triggered by AID, the adverse effect of antibody diversification. Carcinogenesis 28 (2007) 2427-2433
50. Petersen S., Casellas R., Reina-San-Martin B., Chen H.T., Difilippantonio M.J., Wilson P.C., Hanitsch L., Celeste A., Muramatsu M., Pilch D.R., et al. AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching. Nature 414 (2001) 660-665
51. Potter M. Neoplastic development in plasma cells. Immunol. Rev. 194 (2003) 177-195
52. Rajewsky K. Clonal selection and learning in the antibody system. Nature 381 (1996) 751-758
53. Ramiro A.R., Jankovic M., Eisenreich T., Difilippantonio S., Chen-Kiang S., Muramatsu M., Honjo T., Nussenzweig A., and Nussenzweig M.C. AID is required for c-myc/IgH chromosome translocations in vivo. Cell 118 (2004) 431-438
54. Ramiro A.R., Jankovic M., Callen E., Difilippantonio S., Chen H.T., McBride K.M., Eisenreich T.R., Chen J., Dickins R.A., Lowe S.W., et al. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature 440 (2006) 105-109
55. Reina-San-Martin B., Difilippantonio S., Hanitsch L., Masilamani R.F., Nussenzweig A., and Nussenzweig M.C. H2AX is required for recombination between immunoglobulin switch regions but not for intra-switch region recombination or somatic hypermutation. J. Exp. Med. 197 (2003) 1767-1778
56. Reina-San-Martin B., Chen H.T., Nussenzweig A., and Nussenzweig M.C. ATM is required for efficient recombination between immunoglobulin switch regions. J. Exp. Med. 200 (2004) 1103-1110
57. Revy P., Muto T., Levy Y., Geissmann F., Plebani A., Sanal O., Catalan N., Forveille M., Dufourcq-Labelouse R., Gennery A., et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102 (2000) 565-575
58. Rodriguez A., Vigorito E., Clare S., Warren M.V., Couttet P., Soond D.R., van Dongen S., Grocock R.J., Das P.P., Miska E.A., et al. Requirement of bic/microRNA-155 for normal immune function. Science 316 (2007) 608-611
59. Roldo C., Missiaglia E., Hagan J.P., Falconi M., Capelli P., Bersani S., Calin G.A., Volinia S., Liu C.G., Scarpa A., and Croce C.M. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J. Clin. Oncol. 24 (2006) 4677-4684
60. Sayegh C.E., Quong M.W., Agata Y., and Murre C. E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat. Immunol. 4 (2003) 586-593
61. Schmidt E.V., Pattengale P.K., Weir L., and Leder P. Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: A pre-B-cell lymphoma model. Proc. Natl. Acad. Sci. USA 85 (1988) 6047-6051
62. Taganov K.D., Boldin M.P., Chang K.J., and Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103 (2006) 12481-12486
63. Tam W. Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA. Gene 274 (2001) 157-167
64. Teng G., Hakimpour P., Landgraf P., Rice A., Tuschl T., Casellas R., and Papavasilious F.N. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 28 (2008) 621-629 this issue
65. Thai T.H., Calado D.P., Casola S., Ansel K.M., Xiao C., Xue Y., Murphy A., Frendewey D., Valenzuela D., Kutok J.L., et al. Regulation of the germinal center response by microRNA-155. Science 316 (2007) 604-608
66. Thomson J.M., Newman M., Parker J.S., Morin-Kensicki E.M., Wright T., and Hammond S.M. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 20 (2006) 2202-2207
67. van den Berg A., Kroesen B.J., Kooistra K., de Jong D., Briggs J., Blokzijl T., Jacobs S., Kluiver J., Diepstra A., Maggio E., and Poppema S. High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes Cancer 37 (2003) 20-28
68. Vigorito E., Perks K.L., Abreu-Goodger C., Bunting S., Xiang Z., Kohlhaas S., Das P.P., Miska E.A., Rodriguez A., Bradley A., et al. microRNA-155 Regulates the Generation of Immunoglobulin Class-Switched Plasma Cells. Immunity 27 (2007) 847-859
69. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103 (2006) 2257-2261
70. Wakae K., Magor B.G., Saunders H., Nagaoka H., Kawamura A., Kinoshita K., Honjo T., and Muramatsu M. Evolution of class switch recombination function in fish activation-induced cytidine deaminase, AID. Int. Immunol. 18 (2006) 41-47
71. Yagi T., Ikawa Y., Yoshida K., Shigetani Y., Takeda N., Mabuchi I., Yamamoto T., and Aizawa S. Homologous recombination at c-fyn locus of mouse embryonic stem cells with use of diptheria toxin A-fragment gene in negative selection. Proc. Natl. Acad. Sci. USA 87 (1990) 9918-9922
72. Yoshikawa K., Okazaki I.M., Eto T., Kinoshita K., Muramatsu M., Nagaoka H., and Honjo T. AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science 296 (2002) 2033-2036